Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma I Andersson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Research|February 28, 2018
Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia PatientsLiye He, Jing Tang, Emma I Andersson, et al.
Cancers|March 20, 2020
<i>STAT3</i> Mutation Is Associated with STAT3 Activation in CD30<sup>+</sup> ALK<sup>-</sup> ALCLEmma I Andersson, Oscar Brück, Till Braun, et al.
Scientific Reports|February 9, 2018
Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8<sup>+</sup> TCR-Vβ<sup>+</sup> expansionsAnna Lissina, James E McLaren, Mette Ilander, et al.
Haematologica|October 5, 2014
The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemiaHanna L M Rajala, Thomas Olson, Michael J Clemente, et al.
Oncotarget|February 11, 2017
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitorsPaavo O Pietarinen, Christopher A Eide, Pilar Ayuda-Durán, et al.
Blood|April 19, 2013
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemiaHanna L M Rajala, Samuli Eldfors, Heikki Kuusanmäki, et al.
Nature Communications|April 21, 2018
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic targetOlli Dufva, Matti Kankainen, Tiina Kelkka, et al.
Biomarker Research|October 28, 2020
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemiaCarlos Cuesta-Mateos, Patricia Fuentes, Alexandra Schrader, et al.
The New England Journal of Medicine|May 18, 2012
Somatic STAT3 mutations in large granular lymphocytic leukemiaHanna L M Koskela, Samuli Eldfors, Pekka Ellonen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Research|February 28, 2018
Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia PatientsLiye He, Jing Tang, Emma I Andersson, et al.
Cancers|March 20, 2020
<i>STAT3</i> Mutation Is Associated with STAT3 Activation in CD30<sup>+</sup> ALK<sup>-</sup> ALCLEmma I Andersson, Oscar Brück, Till Braun, et al.
Scientific Reports|February 9, 2018
Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8<sup>+</sup> TCR-Vβ<sup>+</sup> expansionsAnna Lissina, James E McLaren, Mette Ilander, et al.
Haematologica|October 5, 2014
The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemiaHanna L M Rajala, Thomas Olson, Michael J Clemente, et al.
Oncotarget|February 11, 2017
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitorsPaavo O Pietarinen, Christopher A Eide, Pilar Ayuda-Durán, et al.
Blood|April 19, 2013
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemiaHanna L M Rajala, Samuli Eldfors, Heikki Kuusanmäki, et al.
Nature Communications|April 21, 2018
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic targetOlli Dufva, Matti Kankainen, Tiina Kelkka, et al.
Biomarker Research|October 28, 2020
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemiaCarlos Cuesta-Mateos, Patricia Fuentes, Alexandra Schrader, et al.
The New England Journal of Medicine|May 18, 2012
Somatic STAT3 mutations in large granular lymphocytic leukemiaHanna L M Koskela, Samuli Eldfors, Pekka Ellonen, et al.
Pageof 1